ArQule and Daiichi Sankyo expand collaboration to produce drug candidates for cancer

ArQule and Daiichi Sankyo expand collaboration to produce drug candidates for cancer
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the expansion of their research, development and license agreement for the discovery of novel kinase inhibitors in the field of oncology. This expanded agreement establishes a third therapeutic target, with an option for a fourth, in the field of oncology, and it includes a two-year extension based on the application of the proprietary …
Read more on News-Medical-Net

Health Events 1014
Healthy Happenings
Read more on Hernando Today

[Dish] ‘Fair and Even-Handed’
Jackson Municipal Judge Ali ShamsidDeen is not trying to be a politically divisive figure, but his background as a editor of the Jackson Advocate in the 1990s and an associate of the law firm Lumumba and Freelon, suggests a controversial bent.
Read more on Jackson Free Press